ArmaGen Technologies, Inc. - Product Pipeline Review - 2012 New Report


Naperville, IL -- (SBWire) -- 09/24/2012 --ArmaGen Technologies, Inc. - Product Pipeline Review - 2012 provides data on the ArmaGen Technologies, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- ArmaGen Technologies, Inc. - Brief ArmaGen Technologies, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ArmaGen Technologies, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of ArmaGen Technologies, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the ArmaGen Technologies, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate ArmaGen Technologies, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of ArmaGen Technologies, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the ArmaGen Technologies, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with ArmaGen Technologies, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of ArmaGen Technologies, Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of ArmaGen Technologies, Inc.; ArmaGen Technologies, Inc. - Key Therapeutics; ArmaGen Technologies, Inc. - Pipeline Overview and Promising Molecules; ArmaGen Technologies, Inc. - News; ArmaGen Technologies, Inc. - Latest Updates; ArmaGen Technologies, Inc. - Pipeline; ArmaGen Technologies, Inc. - Discontinued/Dormant Projects

To view table of contents for this market report please visit:

Media Relations Contact

Web Master

View this press release online at: